Opinion|Videos|December 8, 2023

EMERALD Subgroup Analysis in Patients with Coexisting PIK3CA and TP53 Mutations

Dr. Hope Rugo discusses EMERALD subgroup analysis, safety, and efficacy in patients with coexisting resistance mutations.


Latest CME